Driul L

No ORCID on file · 12 papers in corpus · active 2022-2026

Study types

  • article 2
  • other 2
  • case-report 1

Condition tags

  • endometriosis 4
  • adenomyosis 3
  • chronic_pelvic_pain 2
  • dyspareunia 2
  • dysmenorrhea 1
  • irritable_bowel_syndrome 1
other 2026
BMC women's health ·doi:10.1186/s12905-026-04348-8

BACKGROUND: Pain is the primary symptom of endometriosis and may progress into a chronic, acyclic condition driven by neuroinflammatory mechanisms, leading to neuropathic and ultimately nociplastic pain. Central sensitization, a form of noc…

2026
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox15040523

We evaluated the interplay between systemic total antioxidant capacity (TAC), oxidative stress (OS) (lipid hydroperoxides), inflammation, iron status, and oral contraception (OC) use in 182 healthy 23-year-old women (76 OC-users, and 106 no…

2026
Journal of robotic surgery ·doi:10.1007/s11701-026-03445-y

BackgroundOptimized perioperative analgesia is a critical component of Enhanced Recovery After Surgery (ERAS) pathways in robotic-assisted laparoscopic hysterectomy (RALH). In high-volume robotic programs, predictable pain control may influ…

2025
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare13151780

Iatrogenic urinary tract injury is a known complication of pelvic surgery, most commonly occurring during gynecological procedures. The bladder and ureters are particularly vulnerable due to their close anatomical proximity to the uterus. U…

2025
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare13050485

Introduction: Actinomyces are commensal bacteria that colonize various sites in the human body. Under certain predisposing conditions, they can proliferate and cause granulomatous inflammation in different tissues. Pelvic actinomycosis is a…

article 2025
Biomolecules ·doi:10.3390/biom15040493

This feasibility study explores the potential of salivary microRNAs (miRNAs) as non-invasive biomarkers for diagnosing endometriosis and assessing treatment response. Almost one-third of patients with endometriosis do not respond to the sta…

2025
Cells ·doi:10.3390/cells14201590

Background: The tumor microenvironment offers a new perspective in gynecologic oncology. In ovarian cancer, numerous preclinical studies, especially organoid models, have highlighted cellular, immune, and biochemical mechanisms. Beyond thes…

other 2024
Biomedicines ·doi:10.3390/biomedicines12020463

The 2022 Delphi revision of the MUSA (Morphological Uterus Sonographic Assessment) criteria for the ultrasound diagnosis of adenomyosis divides the ultrasound signs for diagnosis into direct and indirect ones, considering the presence of at…

case-report 2024
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare12100988

Uterine rupture is a rare and life-threatening condition. It usually occurs in patients with uterine scars (most commonly for a previous myomectomy or caesarean section), but it can also affect an unharmed uterus. This complication is more …

article 2023
Journal of personalized medicine ·doi:10.3390/jpm13121646

BACKGROUND: Endometriosis is a gynecological condition affecting up to 10% of women of reproductive age and characterized by chronic pain. Pain is the major cause of the impairment of quality of life in all aspects of these patients. Previo…

2023
Frontiers in oncology ·doi:10.3389/fonc.2023.1199582
2022
Frontiers in oncology ·doi:10.3389/fonc.2022.1009341

Data about the oncological outcomes in women with borderline ovarian tumor (BOT) undergoing uterine-sparing surgery without ovarian preservation are poor. We aimed to assess the oncological outcomes in women with BOT undergoing uterine-spar…